Sadeghian G, Nilfroushzadeh M A, Iraji F
Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran.
Clin Exp Dermatol. 2007 Jul;32(4):371-4. doi: 10.1111/j.1365-2230.2007.02405.x. Epub 2007 Mar 21.
Cutaneous leishmaniasis (CL) is a serious public health problem in many tropical and subtropical regions of the world. Treatment of CL can prevent disfiguring scars.
The efficacy of local heat therapy by radiofrequency (RF) was compared with intralesional injection of meglumine antimoniate in the treatment of CL.
This was a randomized clinical trial. Patients with antroponotic cutaneous leishmaniasis (ACL) in the Isfahan province of Iran were enrolled in the study if the examination of a smear from a suspected CL lesion was confirmed positive for Leishmania. Patients were randomly allocated to one of two treatment groups. Group A was treated by heat therapy by RF at 50 degrees C for 30 s once weekly for 4 weeks, and group B was treated with intralesional injection of meglumine antimoniate once weekly for 4 weeks. Follow-up lasted 6 months. Response to treatment was classified as complete (lesions flattened, no induration, and epidermal creases had appeared), partial (reduction in lesion size, but without the appearance of epidermal creases) and poor (no reduction in lesion size).
Of 117 participants, 57 patients with 83 lesions in group A and 60 patients with 94 lesions in group B completed the study and were followed up for 6 months. Complete, partial and poor response to treatment were 80.7%, 12% and 7.3% in group A, and 55.3%, 21.27% and 23.40% in group B, respectively (P = 0.001). In both groups, there was no relapse in patients with complete response after 6 months of follow-up.
Heat therapy with thermogenerator RF can be used as an efficacious treatment in the lesions of CL. It is more effective than the conventional treatment with intralesional meglumine antimoniate injection.
皮肤利什曼病(CL)是世界上许多热带和亚热带地区的一个严重公共卫生问题。CL的治疗可预防毁容性瘢痕。
比较射频(RF)局部热疗法与病灶内注射葡甲胺锑酸盐治疗CL的疗效。
这是一项随机临床试验。如果疑似CL病变涂片检查确诊为利什曼原虫阳性,则伊朗伊斯法罕省的人兽共患皮肤利什曼病(ACL)患者纳入本研究。患者被随机分配到两个治疗组之一。A组采用射频热疗法,在50摄氏度下治疗30秒,每周一次,共4周;B组采用病灶内注射葡甲胺锑酸盐,每周一次,共4周。随访持续6个月。治疗反应分为完全缓解(病变变平,无硬结,出现表皮皱纹)、部分缓解(病变大小缩小,但未出现表皮皱纹)和疗效不佳(病变大小未缩小)。
117名参与者中,A组57例患者83个病灶,B组60例患者94个病灶完成研究并随访6个月。A组治疗的完全缓解、部分缓解和疗效不佳分别为80.7%、12%和7.3%,B组分别为55.3%、21.27%和23.40%(P = 0.001)。两组中,完全缓解的患者在随访6个月后均未复发。
射频热发生器热疗法可作为CL病变的有效治疗方法。它比传统的病灶内注射葡甲胺锑酸盐治疗更有效。